Penetration of linezolid and tedizolid in cerebrospinal fluid of mouse and impact of blood–brain barrier disruption
Abstract Penetration of antimicrobial treatments into the cerebrospinal fluid is essential to successfully treat infections of the central nervous system. This penetration is hindered by different barriers, including the blood–brain barrier, which is the most impermeable. However, inflammation may l...
Saved in:
Main Authors: | Marin Lahouati, Mélanie Oudart, Philippe Alzieu, Candice Chapouly, Antoine Petitcollin, Fabien Xuereb |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.70100 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linezolid and tedizolid adverse effects: a review on serotonin syndrome, myelosuppression, neuropathies, and lactic acidosis
by: Adam Greenfield, et al.
Published: (2025-01-01) -
Linezolid and serotonin syndrome
by: Haytham A. Wali
Published: (2025-02-01) -
Investigation in blood-brain barrier integrity and susceptibility to immune cell penetration in a mouse model of Dravet syndrome
by: Cristina Alonso, et al.
Published: (2025-03-01) -
Probable Linezolid-Induced Pancytopenia
by: Nita Lakhani, et al.
Published: (2005-01-01) -
Chemokine associations with blood cerebrospinal fluid (CSF) barrier permeability and delirium
by: Paul Denver, et al.
Published: (2025-02-01)